Literature DB >> 2317837

In vivo effect of the tetrapeptide, N-acetyl-Ser-Asp-Lys-Pro, on the G1-S transition of rat hepatocytes.

M N Lombard1, D Sotty, J Wdzieczak-Bakala, M Lenfant.   

Abstract

The synthetic molecule N-Acetyl-Ser-Asp-Lys-Pro (Ac-SDKP), corresponding to the low molecular weight inhibitory factor preventing in vivo haematopoietic stem cell (CFU-S) entry into DNA synthesis, was tested in two heterologous systems in vivo: adult regenerating rat liver and 10-day-old rat hepatocytes synchronized by an irritating trigger. In both systems, it was shown that doses of 2-8 micrograms kg-1 of tetrapeptide inhibited 50-70% of the hepatocyte G1-S transitions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2317837     DOI: 10.1111/j.1365-2184.1990.tb01336.x

Source DB:  PubMed          Journal:  Cell Tissue Kinet        ISSN: 0008-8730


  11 in total

1.  Renal release of N-acetyl-seryl-aspartyl-lysyl-proline is part of an antifibrotic peptidergic system in the kidney.

Authors:  Cesar A Romero; Nitin Kumar; Pablo Nakagawa; Morel E Worou; Tang-Dong Liao; Edward L Peterson; Oscar A Carretero
Journal:  Am J Physiol Renal Physiol       Date:  2018-11-07

2.  Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats.

Authors:  H Peng; O A Carretero; L Raij; F Yang; A Kapke; N E Rhaleb
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

3.  Effect of N-acetyl-seryl-aspartyl-lysyl-proline on DNA and collagen synthesis in rat cardiac fibroblasts.

Authors:  N E Rhaleb; H Peng; P Harding; M Tayeh; M C LaPointe; O A Carretero
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

4.  Long-term effect of N-acetyl-seryl-aspartyl-lysyl-proline on left ventricular collagen deposition in rats with 2-kidney, 1-clip hypertension.

Authors:  N E Rhaleb; H Peng; X P Yang; Y H Liu; D Mehta; E Ezan; O A Carretero
Journal:  Circulation       Date:  2001-06-26       Impact factor: 29.690

5.  N-acetyl-seryl-aspartyl-lysyl-proline stimulates angiogenesis in vitro and in vivo.

Authors:  Dahai Wang; Oscar A Carretero; Xiao-Yi Yang; Nour-Eddine Rhaleb; Yun-He Liu; Tang-Dong Liao; Xiao-Ping Yang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-07-15       Impact factor: 4.733

6.  A Small Peptide Ac-SDKP Inhibits Radiation-Induced Cardiomyopathy.

Authors:  Umesh C Sharma; Swati D Sonkawade; Joseph A Spernyak; Sandra Sexton; Juliane Nguyen; Suraj Dahal; Kristopher M Attwood; Anurag K Singh; Jop H van Berlo; Saraswati Pokharel
Journal:  Circ Heart Fail       Date:  2018-08       Impact factor: 8.790

7.  Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline.

Authors:  M Azizi; A Rousseau; E Ezan; T T Guyene; S Michelet; J M Grognet; M Lenfant; P Corvol; J Ménard
Journal:  J Clin Invest       Date:  1996-02-01       Impact factor: 14.808

8.  Ac-SDKP reverses inflammation and fibrosis in rats with heart failure after myocardial infarction.

Authors:  Fang Yang; Xiao-Ping Yang; Yun-He Liu; Jiang Xu; Oscar Cingolani; Nour-Eddine Rhaleb; Oscar A Carretero
Journal:  Hypertension       Date:  2003-12-22       Impact factor: 10.190

9.  Fragment-based design for the development of N-domain-selective angiotensin-1-converting enzyme inhibitors.

Authors:  Ross G Douglas; Rajni K Sharma; Geoffrey Masuyer; Lizelle Lubbe; Ismael Zamora; K Ravi Acharya; Kelly Chibale; Edward D Sturrock
Journal:  Clin Sci (Lond)       Date:  2014-02       Impact factor: 6.124

10.  Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme.

Authors:  Geoffrey Masuyer; Ross G Douglas; Edward D Sturrock; K Ravi Acharya
Journal:  Sci Rep       Date:  2015-09-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.